Leonardo Borras

Company: CDR-Life

Job title: Chief Scientific Officer

Seminars:

Developing Effective TCR-like Antibody Based T-Cell Engagers for Therapeutics Use 3:45 pm

Technology enables rapid isolation of selective high affinity antibodies against peptide-MHC complexes Utilizing the M-gager® platform to make highly specific and effective pMHC targeting T-cell engagers Current focus on cancer testis antigens and other highly prevalent cancer targetsRead more

day: Conference Day One

Panel: Comparing the Characteristics of TCR-T Cell Therapies & TCR Bispecifics (& More!) to Reaffirm their Unique Benefits 1:45 pm

Comparing relative affinities, potencies and safety considerations of T-cell therapies and bispecifics Assessing indications and patients where each TCR modality could be best suited to treat What other modalities can TCR therapies venture into in the future?Read more

day: Conference Day One